ClinicalTrials.gg
RecruitingNCT07114380Updated Nov 18, 2026

Investigation of Cold Snare Polypectomy for Removing 10-20 mm 0-Ip Colorectal Polyp

An interventional study of Cold snare polypectomy in 10-20 mm Pedunculated Colorectal Polyp, sponsored by National Taiwan University Hospital. Recruiting at 5 sites in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Not applicable
Ages
20 Years and older
Sex
All
01

Study summary

This is a multicenter, single-arm feasibility study conducted across multiple hospitals in Taiwan. The goal of this trial is to evaluate whether cold snare polypectomy is a feasible and safe method for removing 10-20 mm pedunculated colorectal polyps.

The main questions it aims to answer are:

  1. Can cold snare polypectomy achieve complete removal of 10-20 mm pedunculated polyps?
  2. What are the rates and types of complications associated with this technique?

Participants will:

  1. Undergo colonoscopy as clinically indicated
  2. Have 10-20 mm pedunculated polyps removed using cold snare polypectomy if eligible
  3. Be monitored for post-procedure outcomes, including pathology results and any complications
Read the detailed description

This is a prospective, multicenter, single-arm clinical trial designed to evaluate the feasibility and safety of cold snare polypectomy (CSP) for the removal of 10-20 mm pedunculated (0-Ip) colorectal polyps. While CSP is widely recommended for polyps \<10 mm due to its favorable safety profile and comparable efficacy to hot snare polypectomy (HSP), its application for larger pedunculated polyps remains insufficiently studied, particularly given concerns regarding bleeding risk.

The study will enroll 120 adult participants undergoing colonoscopy at one of five hospitals in Taiwan. Participants found to have 10-20 mm 0-Ip polyps that are deemed amenable to CSP will undergo cold snare resection by experienced endoscopists. Standard pre- and post-procedure care will be followed. Polyp characteristics, resection outcomes, and complications (e.g., immediate or delayed bleeding, perforation, emergency visits) will be recorded.

Primary endpoints include technical success (complete removal as assessed by endoscopy and pathology) and safety (rate of adverse events such as bleeding or perforation). Clinical and procedural data will be collected prospectively, and statistical analysis will be conducted to identify predictors of CSP failure using univariate and multivariate models.

This study aims to fill a critical knowledge gap in the literature regarding the appropriateness of CSP for larger pedunculated lesions and inform future guideline recommendations.

02

Conditions studied

  • 10-20 mm Pedunculated Colorectal Polyp

Browse trials for

Keywords

  • cold snare polypectomy
  • pedunculated polyp
  • efficacy
  • safety
03

In context

Polyps

312 studies on the registry are indexed under Polyps; 59 are open to participants now.

This study's planned enrollment of 120 is below the median of 150 across 204 interventional studies indexed under Polyps.

Browse Polyps studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,617 studies on the registry; 575 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 20 years
  • Undergoing colonoscopy for any clinical indication
  • Found to have a 10-20 mm pedunculated colorectal polyp suitable for cold snare polypectomy

Exclusion criteria

Exclusion Criteria:

  • Age \< 20 years
  • Medical to colonoscopy or polypectomy (e.g., recent myocardial infarction, stroke, severe unstable cardiovascular disease, acute peritonitis, fulminant colitis, perforation, or toxic megacolon)
  • Inadequate bowel preparation preventing complete colonoscopy or safe polypectomy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Cold snare polypectomy

    Participants in this single-arm study will undergo cold snare polypectomy (CSP) for removal of 10-20 mm pedunculated colorectal polyps identified during clinically indicated colonoscopy. CSP will be performed using standard cold snares without electrocautery. The procedure will be conducted by experienced endoscopists, and all peri-procedural care will follow routine clinical protocols. Outcomes will include complete resection rate, procedure time, and occurrence of adverse events such as immediate or delayed bleeding, perforation, and emergency visits.

    Device: Cold snare polypectomy

Interventions

  • DeviceCold snare polypectomy

    Unlike traditional hot snare polypectomy or endoscopic mucosal resection, which use electrocautery to resect larger or pedunculated polyps, cold snare polypectomy uses mechanical transection alone without cautery. The procedure is performed using a dedicated cold snare by experienced endoscopists.

06

What researchers measure

Primary outcomes

  1. Cold snare polypectomy successful resection rate

    The investigators will record whether each polyp is removed by cold snare polypectomy with or without resistance. These will be considered successful resection cases. Polyps that cannot be removed by cold snare polypectomy and require switching to hot snare polypectomy will be considered failed resection cases.

    Time frame: From the start of the colonoscopy to completion of the procedure, typically within 1 hour)

Secondary outcomes

  1. Number of Polyps with Immediate Bleeding After Cold Snare Polypectomy

    Definition: Immediate bleeding would be assessed and graded during the procedure. The severity grades were listed as followed, 1. Grade 1: Spontaneous hemostasis within 1 minute 2. Grade 2: Continuous but decreased oozing over 1 minute 3. Grade 3: Continuous oozing over 1 minute 4. Grade 4: Active spurting Unit of Measure: Number of polyps with immediate bleeding, stratified by grade

    Time frame: From the start of the colonoscopy to completion of the procedure, typically within 1 hour.

  2. Number of Participants with Delayed Bleeding After Cold Snare Polypectomy

    Definition: Any bleeding episode occurring after the patient has left the endoscopy unit and within 14 days post-polypectomy, classified as: Mild: Bleeding stops spontaneously without medical intervention Severe: Hemoglobin drop \>2 g/dL from baseline, need for blood transfusion, or requirement of endoscopic, angiographic, or surgical hemostasis Unit of Measure: Number of participants with delayed bleeding

    Time frame: From completion of colonoscopy until the date of first documented event, assessed up to 14 days post-procedure.

  3. Number of Participants with Perforation

    Definition: Any full-thickness defect of the colonic wall identified during or after the procedure. Unit of Measure: Number of participants with perforation

    Time frame: From start of colonoscopy until the date of first documented event, assessed up to 14 days post-procedure.

  4. Number of Participants with Post-Polypectomy Emergency Department Visits

    Definition: Any unplanned emergency department visit related to post-polypectomy complications. Unit of Measure: Number of participants with emergency department visits

    Time frame: From start of colonoscopy until the date of first documented event, assessed up to 14 days post-procedure.

  5. Polypectomy time

    Description: Time from when the snaring instrument first appears on the colonoscopy screen to when colonoscope withdrawal resumes after polypectomy. Unit of Measure: Seconds

    Time frame: From the start of the colonoscopy to completion of the procedure, typically within 1 hour.

  6. Withdrawal Time

    Description: Total time taken to withdraw the colonoscope from cecum to anus Unit of Measure: Minutes

    Time frame: From the start of the colonoscopy to completion of the procedure, typically within 1 hour.

  7. Number of Polyps with En Bloc Resection

    Description: Whether the polyp was removed in a single piece (en bloc). Unit of Measure: Number of polyps with en bloc resection

    Time frame: From the start of the colonoscopy to completion of the procedure, typically within 1 hour.

  8. Number of Polyps with Complete Histologic Resection

    Description: Whether pathology confirms tumor-free margins in the resected specimen. Unit of Measure: Number of polyps with complete histologic resection

    Time frame: From end of colonoscopy exam to pathology report, usually within 2 weeks.

  9. Number of Polyps Requiring Prophylactic Hemoclipping

    Description: Whether hemoclips were applied prophylactically after cold snare polypectomy. Unit of Measure: Number of polyps requiring prophylactic hemoclipping

    Time frame: From the start of the colonoscopy to completion of the procedure, typically within 1 hour.

  10. Number of Polyps Requiring Submucosal Injection

    Description: Whether submucosal injection was required before or during cold snare polypectomy. Unit of Measure: Number of polyps requiring submucosal injection

    Time frame: From the start of the colonoscopy to completion of the procedure, typically within 1 hour.

  11. Number of Polyps Successfully Retrieved

    Description: The number of resected polyps that are successfully retrieved and submitted for histologic evaluation. Unit of Measure: Number of polyps successfully retrieved

    Time frame: From the start of the colonoscopy to completion of the procedure, typically within 1 hour.

07

Study locations

5 of 5 sites recruiting
08

References and documents

Publications

  • Tseng CH, Chang LC, Wu JL, Chang CY, Chen CY, Chen PJ, Shun CT, Hsu WF, Chen YN, Chen CC, Huang TY, Tu CH, Chen MJ, Chou CK, Lee CT, Chen PY, Lin JT, Wu MS, Chiu HM. Bleeding Risk of Cold Versus Hot Snare Polypectomy for Pedunculated Colorectal Polyps Measuring 10 mm or Less: Subgroup Analysis of a Large Randomized Controlled Trial. Am J Gastroenterol. 2024 Nov 1;119(11):2233-2240. doi: 10.14309/ajg.0000000000002847. Epub 2024 May 9. PubMed 38775310 ↗
  • Ferlitsch M, Hassan C, Bisschops R, Bhandari P, Dinis-Ribeiro M, Risio M, Paspatis GA, Moss A, Libanio D, Lorenzo-Zuniga V, Voiosu AM, Rutter MD, Pellise M, Moons LMG, Probst A, Awadie H, Amato A, Takeuchi Y, Repici A, Rahmi G, Koecklin HU, Albeniz E, Rockenbauer LM, Waldmann E, Messmann H, Triantafyllou K, Jover R, Gralnek IM, Dekker E, Bourke MJ. Colorectal polypectomy and endoscopic mucosal resection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2024. Endoscopy. 2024 Jul;56(7):516-545. doi: 10.1055/a-2304-3219. Epub 2024 Apr 26. PubMed 38670139 ↗
  • Kaltenbach T, Anderson JC, Burke CA, Dominitz JA, Gupta S, Lieberman D, Robertson DJ, Shaukat A, Syngal S, Rex DK. Endoscopic Removal of Colorectal Lesions-Recommendations by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020 Mar;158(4):1095-1129. doi: 10.1053/j.gastro.2019.12.018. Epub 2020 Feb 11. No abstract available. PubMed 32122632 ↗
  • Copland AP, Kahi CJ, Ko CW, Ginsberg GG. AGA Clinical Practice Update on Appropriate and Tailored Polypectomy: Expert Review. Clin Gastroenterol Hepatol. 2024 Mar;22(3):470-479.e5. doi: 10.1016/j.cgh.2023.10.012. Epub 2023 Nov 28. PubMed 38032585 ↗
  • Qu J, Jian H, Li L, Zhang Y, Feng B, Li Z, Zuo X. Effectiveness and safety of cold versus hot snare polypectomy: A meta-analysis. J Gastroenterol Hepatol. 2019 Jan;34(1):49-58. doi: 10.1111/jgh.14464. Epub 2018 Sep 26. PubMed 30176072 ↗
  • Chang LC, Chang CY, Chen CY, Tseng CH, Chen PJ, Shun CT, Hsu WF, Chen YN, Chen CC, Huang TY, Tu CH, Chen MJ, Chou CK, Lee CT, Chen PY, Wu MS, Chiu HM. Cold Versus Hot Snare Polypectomy for Small Colorectal Polyps : A Pragmatic Randomized Controlled Trial. Ann Intern Med. 2023 Mar;176(3):311-319. doi: 10.7326/M22-2189. Epub 2023 Feb 21. PubMed 36802753 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Mar 2028, 31 months after the start.

Of 68 non-industry interventional studies with no phase under Polyps, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 31 months is above that.

Counting every sponsor, half of 79 studies reached it within 23 months; a quarter within 12 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 20, 2025
First posted
Aug 11, 2025
StartActual
Aug 25, 2025
Primary completionEst.
Mar 2028
CompletionEst.
Apr 2028
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07114380
Responsible party
Sponsor
First posted
Aug 11, 2025
Start date
Aug 25, 2025
Primary completion
Mar 2028 (estimated)
Completion
Apr 2028 (estimated)
Last update
Nov 18, 2026

Study contacts

Hsin-Yun Wu, MD
Contact
kimwu010063@gmail.com
+886978232595
Li-Chun Chang, MD, PhD
Contact
lichunchang@ntu.edu.tw
+886972651258
Li-Chun Chang, MD, PhD
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion